Evaluation of prognostic markers in severe drug-induced liver disease.
about
Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature reviewCigarette smoking and serum bilirubin subtypes in healthy Korean men: the Korea Medical Institute study.Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials.Prevalence and characteristics of hypoxic hepatitis in the largest single-centre cohort of avian influenza A(H7N9) virus-infected patients with severe liver impairment in the intensive care unit.A Chinese Herbal Decoction, Huoxue Qingyi Decoction, Promotes Rehabilitation of Patients with Severe Acute Pancreatitis: A Retrospective StudyAssociation of serum bilirubin with ischemic stroke outcomes.Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.A nationwide study of the incidence rate of herb-induced liver injury in Korea.Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitusDrug-induced liver injury: is it somehow foreseeable?Association of direct bilirubin level with postoperative outcome in critically ill postoperative patients.Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population.Incidence et facteurs associés à la survenue d’une hépatite médicamenteuse dans une cohorte de patients noirs africains en première phase de traitement antituberculeux à Abidjan (Côte-d’Ivoire)Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects
P2860
Q34116293-F5019B81-1899-4C54-9353-9E2894A4683CQ35884351-24E71899-AC0E-4170-B343-92F0359FC39AQ36022805-2F314E6B-D7B9-48B6-85A7-3CC0FDC0643EQ36526484-7763DC81-6D80-4DF9-9E01-F1329D2B253DQ36773395-04A90B0C-1494-4E51-81CB-5F13865D301AQ37317798-BFB37D3B-845F-485B-9C23-B540227E41ACQ37711165-8BC7D000-20DA-4058-8120-3781C5992BF1Q40151754-70CC391A-26BC-46DB-8F8D-30A3BEF59673Q41939255-A0120E4B-5D6A-4DAA-88FC-C2782459A810Q43109156-FD573E9C-B24D-461A-867C-CAAB0E4B7DEAQ49366575-E443B74B-3F66-4A9D-AF83-8DA7A0699D35Q51629645-0E44E893-EBE2-4B0D-A394-C01ED9625491Q58209104-F5E91E7E-4F7E-4831-8A96-9191DBDFA5CBQ59127640-CF5E94E7-885E-47FD-909F-E5AA1FCEBD51
P2860
Evaluation of prognostic markers in severe drug-induced liver disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evaluation of prognostic markers in severe drug-induced liver disease.
@ast
Evaluation of prognostic markers in severe drug-induced liver disease.
@en
type
label
Evaluation of prognostic markers in severe drug-induced liver disease.
@ast
Evaluation of prognostic markers in severe drug-induced liver disease.
@en
prefLabel
Evaluation of prognostic markers in severe drug-induced liver disease.
@ast
Evaluation of prognostic markers in severe drug-induced liver disease.
@en
P2093
P2860
P356
P1476
Evaluation of prognostic markers in severe drug-induced liver disease.
@en
P2093
Jian-Jiang Fang
Wei-Xing Chen
P2860
P304
P356
10.3748/WJG.V13.I4.628
P407
P577
2007-01-01T00:00:00Z